Label Changes for:
Sodium Iodide I-131 Therapeutic Capsules and Therapeutic Solution
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2012
- Published reports have described salivary and lacrimal gland dysfunction.